Sequana Medical NV | Small-cap | Healthcare
€1.23
-9.44%
| Sequana Medical NV Stock Comparison:
Sequana Medical NV vs Ion BeamSequana Medical NV vs Argenx SESequana Medical NV vs UCB S.ASequana Medical NV vs Fagron NVSequana Medical NV vs Nyxoah S.ASequana Medical NV vs BEL 20 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2018

Income Metrics

Revenue 342.8K
Gross Profit 291.3K 84.98%
Operating Income -5.2M -1,505.34%
Net Income -5.3M -1,560.41%

Balance Sheet Metrics

Total Assets 9.9M
Total Liabilities 54.3M
Shareholders Equity -44.4M

Cash Flow Metrics

Operating Cash Flow -4.6M
Free Cash Flow -3.2M

Revenue & Profitability Trend

Sequana Medical NV Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i105.5K712.2K922.7K370.5K963.3K
Cost of Goods Sold i26.4K164.1K204.6K76.7K202.4K
Gross Profit i79.1K548.0K718.1K293.8K760.9K
Gross Margin % i74.9%77.0%77.8%79.3%79.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i7.4M8.7M8.9M7.2M6.7M
Other Operating Expenses i11.4M21.3M20.4M16.9M11.8M
Total Operating Expenses i18.8M30.0M29.3M24.1M18.6M
Operating Income i-18.2M-28.9M-28.1M-22.6M-17.8M
Operating Margin % i-17,273.0%-4,052.7%-3,044.9%-6,103.5%-1,844.9%
Non-Operating Items
Interest Income i-2.0K131949.9K
Interest Expense i2.6M2.0M880.0K559.8K1.1M
Other Non-Operating Income-----
Pre-tax Income i-44.4M-32.1M-30.4M-23.2M-18.9M
Income Tax i280.4K465.6K386.6K393.3K157.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-44.7M-32.6M-30.8M-23.6M-19.1M
Net Margin % i-42,325.7%-4,572.4%-3,334.1%-6,373.8%-1,983.5%
Key Metrics
EBITDA i-41.1M-29.4M-29.2M-22.2M-17.6M
EPS (Basic) i-€-1.22€-1.35€-1.30€-1.25
EPS (Diluted) i-€-1.22€-1.35€-1.30€-1.25
Basic Shares Outstanding i-26774116227695761821294415310073
Diluted Shares Outstanding i-26774116227695761821294415310073

Income Statement Trend

Sequana Medical NV Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i3.8M2.6M18.9M9.6M11.0M
Short-term Investments i-----
Accounts Receivable i043.1K113.9K81.9K23.6K
Inventory i2.0M2.3M2.6M2.1M1.5M
Other Current Assets11-11
Total Current Assets i6.4M6.3M23.1M12.9M13.4M
Non-Current Assets
Property, Plant & Equipment i1.3M1.2M510.6K75.4K23.2K
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets1.6M1.4M782.2K463.9K-
Total Non-Current Assets i3.5M3.8M2.9M1.8M772.0K
Total Assets i9.9M10.1M26.0M14.7M14.2M
Liabilities
Current Liabilities
Accounts Payable i1.9M2.7M3.2M2.2M2.0M
Short-term Debt i39.8M8.1M4.8M283.0K263.7K
Current Portion of Long-term Debt-----
Other Current Liabilities--1--1-1
Total Current Liabilities i53.2M19.5M15.1M7.2M6.0M
Non-Current Liabilities
Long-term Debt i357.9K9.4M12.8M7.8M7.6M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities---1-1
Total Non-Current Liabilities i1.1M10.1M13.0M8.3M8.1M
Total Liabilities i54.3M29.6M28.2M15.5M14.1M
Equity
Common Stock i4.6M2.9M2.5M1.9M1.6M
Retained Earnings i-250.7M-206.0M-173.5M-142.7M-119.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-44.4M-19.5M-2.2M-786.9K112.8K
Key Metrics
Total Debt i40.1M17.5M17.6M8.1M7.9M
Working Capital i-46.8M-13.2M7.9M5.7M7.5M

Balance Sheet Composition

Sequana Medical NV Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-44.7M-32.6M-30.8M-23.6M-19.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-179.2K563.9K564.4K536.4K255.9K
Working Capital Changes i802.7K-60.0K-414.2K-1.0M488.0K
Operating Cash Flow i-17.8M-28.8M-28.7M-23.5M-17.3M
Investing Activities
Capital Expenditures i-95.1K-710.8K-676.7K-325.8K-138.0K
Acquisitions i-----
Investment Purchases i-4.7K-10.6K--12.4K-4.0K
Investment Sales i--23.6K--
Investing Cash Flow i-99.8K-721.4K-653.1K-338.2K-142.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i10.7M-9.6M07.3M
Debt Repayment i-157.7K-982.4K00-3.2M
Financing Cash Flow i22.2M14.8M38.0M22.8M23.1M
Free Cash Flow i-20.4M-29.8M-28.2M-23.9M-17.1M
Net Change in Cash i4.3M-14.7M8.7M-1.1M5.6M

Cash Flow Trend

Sequana Medical NV Key Financial Ratios

Valuation Ratios

Forward P/E -1.02
Price to Sales 752.29
PEG Ratio -1.02

Profitability Ratios

Profit Margin 74.94%
Operating Margin -17,731.38%
Return on Equity 100.62%
Return on Assets -116.66%

Financial Health

Current Ratio 0.12
Debt to Equity -0.90
Beta 0.01

Per Share Data

EPS (TTM) €-1.22
Book Value per Share €-1.00
Revenue per Share €0.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sequa79.4M--100.62%74.94%-0.90
Ion Beam 333.5M36.452.998.52%1.86%39.39
Argenx SE 36.2B33.975.7824.72%41.03%0.71
UCB S.A 35.1B26.903.6214.30%19.45%29.72
Fagron NV 1.5B17.653.0117.53%9.33%80.02
Nyxoah S.A 257.8M-3.572.62-77.44%65.67%23.79

Financial data is updated regularly. All figures are in the company's reporting currency.